The PD-1-PD-L pathway in immunological tolerance

被引:587
作者
Okazaki, T
Honjo, T
机构
[1] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Grad Sch Med, Century Ctr Excellence Program 21st, Sakyo Ku, Kyoto 6068501, Japan
关键词
D O I
10.1016/j.it.2006.02.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Since the first observation of spontaneous autoimmune diseases in programmed cell death 1 (PD-1) knockout mice, PD-1 has been postulated to have essential roles in the regulation of autoimmunity but the precise mechanism was largely unknown. Recent studies clearly demonstrated that PD-1 has dual roles in immunological tolerance: induction and maintenance of peripheral tolerance. PD-1 ligands (PD-Ls) on antigen-presenting cells have been shown to switch off autoreactive T cells and induce peripheral tolerance, whereas those on parenchymal cells prevent tissue destruction by suppressing effector T cells to maintain tolerance. In addition, PDA and other immuno-inhibitory receptors have been shown to collaborate in the regulation of tolerance. Here, we review recent studies on the role of PDA in immunological tolerance and discuss possible clinical applications of PD-1 manipulation.
引用
收藏
页码:195 / 201
页数:7
相关论文
共 67 条
  • [1] The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
    Ansari, MJI
    Salama, AD
    Chitnis, T
    Smith, RN
    Yagita, H
    Akiba, H
    Yamazaki, T
    Azuma, M
    Iwai, H
    Khoury, SJ
    Auchincloss, H
    Sayegh, MH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) : 63 - 69
  • [2] PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells
    Blank, C
    Brown, I
    Peterson, AC
    Spiotto, M
    Iwai, Y
    Honjo, T
    Gajewski, TF
    [J]. CANCER RESEARCH, 2004, 64 (03) : 1140 - 1145
  • [3] Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis
    Bolland, S
    Ravetch, JV
    [J]. IMMUNITY, 2000, 13 (02) : 277 - 285
  • [4] Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO
  • [5] 2-9
  • [6] SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
    Chemnitz, JM
    Parry, RV
    Nichols, KE
    June, CH
    Riley, JL
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (02) : 945 - 954
  • [7] Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
    Curiel, TJ
    Wei, S
    Dong, HD
    Alvarez, X
    Cheng, P
    Mottram, P
    Krzysiek, R
    Knutson, KL
    Daniel, B
    Zimmermann, MC
    David, O
    Burow, M
    Gordon, A
    Dhurandhar, N
    Myers, L
    Berggren, R
    Hemminki, A
    Alvarez, RD
    Emilie, D
    Curiel, DT
    Chen, LP
    Zou, WP
    [J]. NATURE MEDICINE, 2003, 9 (05) : 562 - 567
  • [8] Dong HD, 1999, NAT MED, V5, P1365
  • [9] Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
  • [10] Association of PDCD1 with susceptibility to systemic lupus erythematosus - Evidence of population-specific effects
    Ferreiros-Vidal, I
    Gomez-Reino, JJ
    Barros, F
    Carracedo, A
    Carreira, P
    Gonzalez-Escribano, F
    Liz, M
    Martin, J
    Ordi, J
    Vicario, JL
    Gonzalez, A
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (08): : 2590 - 2597